Ignite Creation Date:
2025-12-24 @ 6:42 PM
Ignite Modification Date:
2025-12-25 @ 4:12 PM
Study NCT ID:
NCT03021057
Status:
UNKNOWN
Last Update Posted:
2019-04-17
First Post:
2017-01-11
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Pembrolizumab for T/NK-cell lymphomasNK-cell Lymphomas
Sponsor:
The University of Hong Kong